Article
[Case report of the available of interhenotypic recombinant in chronic hepatitis C: the algorithm of individualization of the antiviral therapy].
Georgian medical news - 1 Feb 2013
Stelmakh V, Kozlov V, Komissarov A, Samusenko I, Grudinin M
Abstract excerpt
UNLABELLED: In this particular case report (in vivo the persistence of HCV intergenotipic recombinant form /2/1b/ peripheral blood mononuclear cells of patient) is an example of optimizing the standard antiviral therapy (PegIntron + Rebetol). In this paper we report a patient infected by HCV 1b and, probably, recombinant 2/1b that is detected in peripheral blood mononuclear cells (PBMC). CASE DESCRIPTION: Patient...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
